BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19796075)

  • 1. Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues.
    Thomas M; Kularatne SA; Qi L; Kleindl P; Leamon CP; Hansen MJ; Low PS
    Ann N Y Acad Sci; 2009 Sep; 1175():32-9. PubMed ID: 19796075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors.
    Vlashi E; Sturgis JE; Thomas M; Low PS
    Mol Pharm; 2009; 6(6):1868-75. PubMed ID: 19754150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
    Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
    Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-targeted non-viral DNA vectors for cancer gene therapy.
    Ward CM
    Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Folate receptor-mediated antitumor drugs].
    Zhao J; Cao SL; Zheng XL; Zhao B
    Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of tumor-targeted near infrared probes for fluorescence guided surgery.
    Kelderhouse LE; Chelvam V; Wayua C; Mahalingam S; Poh S; Kularatne SA; Low PS
    Bioconjug Chem; 2013 Jun; 24(6):1075-80. PubMed ID: 23642154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
    Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
    Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
    Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
    Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor detection using folate receptor-targeted imaging agents.
    Sega EI; Low PS
    Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-targeted chemotherapy.
    Leamon CP; Reddy JA
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
    Lu Y; Sega E; Leamon CP; Low PS
    Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate targeting of drug carriers: a mathematical model.
    Ghaghada KB; Saul J; Natarajan JV; Bellamkonda RV; Annapragada AV
    J Control Release; 2005 May; 104(1):113-28. PubMed ID: 15866339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies.
    Gravier J; Schneider R; Frochot C; Bastogne T; Schmitt F; Didelon J; Guillemin F; Barberi-Heyob M
    J Med Chem; 2008 Jul; 51(13):3867-77. PubMed ID: 18553957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of small interfering RNA: approaching effective cancer therapies.
    Pirollo KF; Chang EH
    Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells.
    Gabrielson NP; Pack DW
    J Control Release; 2009 May; 136(1):54-61. PubMed ID: 19217921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate conjugated phosphorylcholine-based polycations for specific targeting in nucleic acids delivery.
    Lam JK; Armes SP; Lewis AL; Stolnik S
    J Drug Target; 2009 Aug; 17(7):512-23. PubMed ID: 19534582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.